Dyslipidemia in patients with chronic and end-stage kidney disease

Jad Omran, Ashraf Al-Dadah, Kevin C. Dellsperger

Research output: Contribution to journalReview article

16 Scopus citations


In this review, we discuss the physiology, diagnosis and treatment of dyslipidemia in patients with chronic and end-stage renal disease. The recent important clinical trials in patients with chronic kidney disease and dyslipidemia are reviewed. Because of the lack of evidence in treating lipid abnormalities in this specific patient population, we propose that future studies should focus on the pathophysiological mechanisms and treatment of dyslipidemia in this special patient population.

Original languageEnglish (US)
Pages (from-to)165-177
Number of pages13
JournalCardioRenal Medicine
Issue number3
Publication statusPublished - Oct 2013



  • Chronic kidney disease
  • Dyslipidemia
  • End-stage renal disease
  • Oxidized low-density lipoprotein

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Urology

Cite this